Standout Papers
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 (2011)
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors (2016)
- Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic (2005)
- Oncogenic PI3K deregulates transcription and translation (2005)
- miR-34 – a microRNA replacement therapy is headed to the clinic (2012)
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34 (2010)
- PDL1 Regulation by p53 via miR-34 (2015)
- Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice (2011)
Immediate Impact
3 by Nobel laureates 24 from Science/Nature 79 standout
Citing Papers
Lipids and Lipid Derivatives for RNA Delivery
2021 Standout
Bone metastasis: mechanisms, therapies, and biomarkers
2020 Standout
Works of Andreas G. Bader being referenced
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
2016 Standout
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andreas G. Bader | 7149 | 5198 | 1540 | 57 | 8.7k | |
| David M. Feldser | 8030 | 6787 | 1760 | 40 | 10.9k | |
| Longbang Chen | 5877 | 4676 | 1638 | 155 | 8.0k | |
| Philip A. Gregory | 7072 | 5828 | 2038 | 55 | 9.0k | |
| Angelo Veronese | 7130 | 6384 | 812 | 53 | 8.7k | |
| Diana Whitaker‐Menezes | 5963 | 4568 | 1961 | 93 | 9.2k | |
| Yin‐Yuan Mo | 6514 | 5446 | 1000 | 91 | 7.9k | |
| Erinn B. Rankin | 3368 | 3083 | 1458 | 69 | 6.8k | |
| Oriol Casanovas | 3784 | 2070 | 2303 | 70 | 6.1k | |
| Hirotaka Osada | 6437 | 4187 | 1694 | 73 | 8.4k | |
| Amaia Lujambio | 4128 | 2745 | 1195 | 53 | 5.9k |
All Works
Loading papers...